Old Web
English
Sign In
Acemap
>
authorDetail
>
Hoshimi Okawa
Hoshimi Okawa
Tohoku University
Pharmacokinetics
Endocrinology
Internal medicine
Hepatocellular carcinoma
Adverse effect
3
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Unique Hydrolysis of an Ester-Type Prodrug of Levodopa in Human Plasma: Relay-Type Role Sharing between Alpha-1 Acid Glycoprotein and Human Serum Albumin
2019
Molecular Pharmaceutics
Kenta Kono
Yukina Fukuchi
Hoshimi Okawa
Ken-ichi Nunoya
Haruo Imawaka
Hiroshi Watanabe
Toru Maruyama
Show All
Source
Cite
Save
Citations (3)
Monitoring Serum Levels of Sorafenib and Its N-Oxide Is Essential for Long-Term Sorafenib Treatment of Patients with Hepatocellular Carcinoma
2015
Tohoku Journal of Experimental Medicine
Miki Shimada
Hoshimi Okawa
Yasuteru Kondo
Takahiro Maejima
Yuta Kataoka
Kanehiko Hisamichi
Masamitsu Maekawa
Masaki Matsuura
Yuko Jin
Masaru Mori
Hiroyuki Suzuki
Tooru Shimosegawa
Nariyasu Mano
Show All
Source
Cite
Save
Citations (18)
A Quantitative HPLC-UV Method for Determination of Serum Sorafenib and Sorafenib N-Oxide and Its Application in Hepatocarcinoma Patients
2014
Tohoku Journal of Experimental Medicine
Miki Shimada
Hoshimi Okawa
Takahiro Maejima
Toshiki Yanagi
Kanehiko Hisamichi
Masaki Matsuura
Kazutoshi Akasaka
Masami Tsuchiya
Yasuteru Kondo
Tooru Shimosegawa
Masaru Mori
Masamitsu Maekawa
Hiroyuki Suzuki
Nariyasu Mano
Show All
Source
Cite
Save
Citations (14)
1